Trial Profile
Immunological efficacy of efavirenz based treatment in HIV-positive naive patients (a pylot study).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2015
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms IMMUNEF
- 04 Aug 2011 New trial record